Struggling with grey hair? Doctors explain why you shouldn’t pluck them Greying hair is a part of ageing process. However, it is unwanted and people tend to seek remedies to get rid of it. According to Dr Priyanka Reddy, founder and chief dermatologist at DNA Skin Clinic, grey hairs, often considered a hallmark of aging, can be a point of concern for many. “While some individuals embrace their silver strands as a natural part of life, others may feel compelled to pluck them out in an attempt to maintain a more youthful appearance. However, there’s more to plucking grey hairs than meets the eye,” Dr. Reddy told Financial Express.com. According to Dr. Reddy, plucking those pesky greys might seem like a quick fix, but it can have its drawbacks. Here’s why: Firstly, plucking grey hairs doesn’t stop more from appearing. Contrary to popular belief, pulling out one grey hair won’t prevent others from sprouting in its place. In fact, plucking them can pose a potential damage to the hair follicle itself. Moreover, repeatedly plucking grey hairs could irritate the scalp and potentially cause inflammation. This irritation may result in discomfort or even lead to infection in some cases. Additionally, continuous plucking might damage the follicle, cause scarring, which could impact future hair growth. Instead of plucking, there are safer ways to manage grey hairs. Consider using hair dyes or embracing the natural aging process. Various hair coloring products are available that can effectively cover grey hairs, providing a temporary solution without causing harm. And look into the underlying medical causes in case of premature greuinv and treat them by consulting a dermatologist. “Remember, plucking grey hairs might offer a momentary solution, but it’s not a permanent fix,” she said.
Services miss estimates; Software better than expected: Services business grew 0.6% q-o-q cc and missed HCLT’s Q3FY23 guidance, mainly due to a 3.8% q-o-q cc decline in the ER&D segment. Growth in the IT&BS segment moderated slightly to 1.6% q-o-qcc but was in line with estimates. BFSI and Life Sciences were the key growth drivers, while communications were the drag among verticals. Growth was led by the Americas region, while Europe and ROW posted declines.
Decline in bookings reflects delays in decision-making: HCLT won 10 large deals in services and three large deals in Software with net-new deal TCV of $2.1bn, down 8% y-o-y. Deal wins were driven by the services portfolio, were centered on cost optimisation and vendor consolidation and came mainly from BFSI, manufacturing and Life Sciences verticals. Management highlighted a ramp-down in discretionary spending in Hitech and communications verticals but pointed to a strong deal pipeline.
FY24 guidance in line with expectations: HCLT has guided for 6-8% y-o-y growth for overall business and 6.5-8.5% y-o-y cc growth in services segment and 18-19% margins in FY24—all in line with our assumptions. We maintain our FY24-25 cc revenue growth and margin estimates and expect HCLT to deliver 6.5% cc revenue growth and 18.4% margins in FY24. However, we lower our earnings forecasts by 2% to factor the higher tax rate indicated by the management.
Also read: MSME listing: How to migrate from NSE SME platform to main board? Check revised criteria
Raise PT: HCLT has fared better in Q4, particularly in North America and BFSI, unlike its peers. However, rising demand uncertainty as a US recession nears remains a concern. HCLT’s stock at CMP trades at 17x PE and offers a 5% yield, which in our view should limit downsides and derating. Hence, we raise our target PE to 17x (16x earlier) and raise our PT to Rs 1,125, offering 8% potential upside.